Format
Sort by
Items per page

Send to

Choose Destination

Best matches for anakinra:

Search results

Items: 1 to 20 of 5663

1.

Inflammasome as a promising therapeutic target for cancer.

Lee C, Do HTT, Her J, Kim Y, Seo D, Rhee I.

Life Sci. 2019 Jun 19:116593. doi: 10.1016/j.lfs.2019.116593. [Epub ahead of print] Review.

PMID:
31228512
2.

Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans.

Manna R, Rigante D.

Mediterr J Hematol Infect Dis. 2019 May 1;11(1):e2019027. doi: 10.4084/MJHID.2019.027. eCollection 2019. Review.

3.

Dr. Tibaldi, et al reply.

Tibaldi J, Saccomanno B, Caorsi R, Ravelli A.

J Rheumatol. 2019 Jun 15. pii: jrheum.190551. doi: 10.3899/jrheum.190551. [Epub ahead of print]

PMID:
31203230
4.

Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.

Ozen S, Demir S, Batu ED.

J Rheumatol. 2019 Jun 15. pii: jrheum.190238. doi: 10.3899/jrheum.190238. [Epub ahead of print]

PMID:
31203219
5.

A familial Mediterranean fever patient with double homozygous mutations treated with anakinra after kidney transplantation.

Hasbal NB, Koc Y, Sevinc M, Unsal A, Basturk T.

Nefrologia. 2019 Jun 11. pii: S0211-6995(19)30095-5. doi: 10.1016/j.nefro.2019.03.012. [Epub ahead of print] English, Spanish. No abstract available.

6.

Long-term outcome after stifle arthroscopy in 82 Western performance horses (2003-2010).

McCoy AM, Smith RL, Herrera S, Kawcak CE, McIlwraith CW, Goodrich LR.

Vet Surg. 2019 Jun 14. doi: 10.1111/vsu.13241. [Epub ahead of print]

PMID:
31199028
7.

Biologic Response Modifiers (BRMs).

Sapkota B, Makandar SN.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 30.

8.

Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Lim SYD, Oon HH.

Biologics. 2019 May 13;13:53-78. doi: 10.2147/BTT.S199862. eCollection 2019. Review.

9.

Correction to: Anakinra in Still's disease: a profile of its use.

Lyseng-Williamson KA.

Drugs Ther Perspect. 2019;35(1):46. doi: 10.1007/s40267-018-0581-4. Epub 2018 Nov 17.

10.

Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.

Helyes Z, Tékus V, Szentes N, Pohóczky K, Botz B, Kiss T, Kemény Á, Környei Z, Tóth K, Lénárt N, Ábrahám H, Pinteaux E, Francis S, Sensi S, Dénes Á, Goebel A.

Proc Natl Acad Sci U S A. 2019 Jun 10. pii: 201820168. doi: 10.1073/pnas.1820168116. [Epub ahead of print]

PMID:
31182576
11.

Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval.

Pascart T, Norberciak L, Ea HK, Graf S, Guggenbuhl P, Lioté F.

Rheumatology (Oxford). 2019 Jun 9. pii: kez203. doi: 10.1093/rheumatology/kez203. [Epub ahead of print]

PMID:
31177284
12.

Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.

Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P.

Best Pract Res Clin Rheumatol. 2018 Aug;32(4):500-510. doi: 10.1016/j.berh.2019.02.003. Epub 2019 Feb 27. Review.

PMID:
31174819
13.

The First Case Series of Cryopyrin-Associated Periodic Syndrome in Korea.

Han JH, Je YJ, Yoon HJ, Ahn JG, Lee JS, Park JW, Park HJ.

Allergy Asthma Immunol Res. 2019 Jul;11(4):583-588. doi: 10.4168/aair.2019.11.4.583.

14.

Inflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapy.

Terrone G, Frigerio F, Balosso S, Ravizza T, Vezzani A.

Epilepsy Behav. 2019 Jun 3. pii: S1525-5050(19)30301-4. doi: 10.1016/j.yebeh.2019.04.028. [Epub ahead of print] Review.

PMID:
31171434
15.

Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome.

Dilena R, Mauri E, Aronica E, Bernasconi P, Bana C, Cappelletti C, Carrabba G, Ferrero S, Giorda R, Guez S, Scalia Catenacci S, Triulzi F, Barbieri S, Calderini E, Vezzani A.

Epilepsia Open. 2019 Mar 27;4(2):344-350. doi: 10.1002/epi4.12317. eCollection 2019 Jun.

16.

Schnitzler syndrome.

Gellrich FF, Günther C.

Hautarzt. 2019 Jun 5. doi: 10.1007/s00105-019-4434-4. [Epub ahead of print] Review.

PMID:
31165908
17.

Exercise upregulates copeptin levels which is not regulated by interleukin-1.

Popovic M, Timper K, Seelig E, Nordmann T, Erlanger TE, Donath MY, Christ-Crain M.

PLoS One. 2019 May 31;14(5):e0217800. doi: 10.1371/journal.pone.0217800. eCollection 2019.

18.

Use of anti-inflammatory agents in clinical islet cell transplants: A qualitative systematic analysis.

Szempruch KR, Banerjee O, McCall RC, Desai CS.

Islets. 2019;11(3):65-75. doi: 10.1080/19382014.2019.1601543.

PMID:
31149871
19.

Inhibition of IL-1β signaling by Anakinra ameliorates pro-inflammatory cytokine responses in Zika virus-infected human blood-brain barrier endothelial cells.

Hueston L, Grau GE, Mahalingam S.

J Infect Dis. 2019 May 22. pii: jiz276. doi: 10.1093/infdis/jiz276. [Epub ahead of print] No abstract available.

PMID:
31116849
20.

Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.

Sargin G, Kose R, Senturk T.

Sao Paulo Med J. 2019 May 8;137(1):39-44. doi: 10.1590/1516-3180.2018.0311101218.

Supplemental Content

Loading ...
Support Center